Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
Chronic Diabetic Foot Ulcers
Interventions
DRUG

Soluble beta-glucan (SBG)

Topical application of SBG to the wound, at least twice a week until complete healing or for 8 maximum weeks

DRUG

Placebo comparator

Topical application of placebo to wound, at least twice a week until compleate healing or for maximum 8 weeks.

Trial Locations (11)

BT9 7AB

Belfast City Hospital, Belfast

BB2 3LR

Royal Blackburn Hospital, Blackburn

BH7 7DW

Royal Bournemouth Hospital, Bournemouth

BS10 5NB

Southmead Hospital, Bristol

G42 9TY

NHS Greater Glasgow and Clyde Victoria, Glasgow

LS1 3EX

Leeds General Infirmary, Leeds

LE5 4PW

Leicester General Hospital, Leicester

M8 5RB

North Manchester Hospital, Manchester

NE1 4LP

Newcastle General Hospital, Newcastle

NN1 5BD

Northampton General Hospital, Northampton

NG5 1PB

Nottingham City Hospital, Nottingham

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY